Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3-month vs 1-month Triptorelin in ICPP
NCT06487143Phase 4Not yet recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Jul 2024
- Primary completion
- Dec 2026
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of triptorelin pamoate in central precocious puberty (CPP) (2 arms), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoint: Proportion of LH ≤ 3 IU/L at 3 months. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
triptorelin pamoate
03
Conditions
central precocious puberty (CPP)
Beyond the preview
Go deeper on NCT06487143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06487143.